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Quercetin, a polyphenolic compound existing in many vegetables, fruits, has antiinflammatory, antiproliferation, and antioxidant
effect on mammalian cells. Quercetin was evaluated for protecting cardiomyocytes from ischemia/reperfusion injury, but its
protective mechanism remains unclear in the current study. The cardioprotective effects of quercetin are achieved by reducing
the activity of Src kinase, signal transducer and activator of transcription 3 (STAT3), caspase 9, Bax, intracellular reactive oxygen
species production, and inflammatory factor and inducible MnSOD expression. Fluorescence two-dimensional differential gel
electrophoresis (2D-DIGE) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)
can reveal the differentially expressed proteins of H9C2 cells treated with H
2
O
2
or quercetin. Although 17 identified proteins were
altered inH
2
O
2
-induced cells, these proteins such as alpha-solubleNSF attachment protein (𝛼-SNAP), Ena/VASP-like protein (Evl),
and isopentenyl-diphosphate delta-isomerase 1 (Idi-1) were reverted by pretreatment with quercetin, which correlates with kinase
activation, DNA repair, lipid, and protein metabolism. Quercetin dephosphorylates Src kinase in H
2
O
2
-induced H9C2 cells and
likely blocks the H
2
O
2
-induced inflammatory response through STAT3 kinase modulation. This probably contributes to prevent
ischemia/reperfusion injury in cardiomyocytes.
1. Introduction
Because of their high incidence andmortality rate, cardiovas-
cular diseases have recently become a primary health concern
worldwide. Myocardial ischemia/reperfusion injury, which
causes excess reactive oxygen species (ROS) production that
can lead to cardiac hypertrophy or dysfunction, is the most
acute cardiovascular disease [1, 2]. In 2010, Chou et al. showed
that ROS may affect intercellular connections and cytoskele-
ton resulting in cell detachment, morphology change, or
death. Src kinase also plays a key role in ROS-induced
phosphorylation and cell damage in cardiomyocytes [2].
The ROS in this study includes hydrogen peroxide
(H
2
O
2
), singlet oxygen (O∙), superoxide (O2−), and the
hydroxyl radical (OH∙). Among these ROS species, H
2
O
2
is the most stable and the most abundant in human cells.
Although the optimal amount of ROS plays an important
role in signal transduction, excess ROS causes cell damage
[3]. H
2
O
2
regulates signal transduction-related proteins by
phosphorylating or modifying the active sites of proteins but
also inhibits phosphatase activity [4].
Quercetin, a type of polyphenolic compound, has anti-
inflammatory, antiproliferation, anti-histamine, and antioxi-
dant effects. Quercetin exists in many types of vegetables and
fruits. Several reports have shown that quercetin has protec-
tive effects on different types of cells, including myocytes,
testis, renal cells, and liver cells in ischemia/reperfusion
injury [5]. A study conducted in 1992 showed that quercetin
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Figure 1: Hydrogen peroxide treatment induces tyrosine phosphorylation in H9C2 cells. (a) Total cell lysates were prepared fromH9C2 cells
treated with a range of H
2
O
2
concentrations (0, 0.2, 0.5, 1, 5, and 10mM) for 20min. H9C2 total cell lysate proteins were separated by 1D SDS-
PAGE, transferred onto a PVDFmembrane (Pall) electrophoretically, and then probed with specific primary antibodies antiphosphotyrosine
and𝛽-actin. (b) Effects of quercetin onH
2
O
2
-induced tyrosine phosphorylation inH9C2 cells.The total cell lysates were prepared fromH9C2
cells pretreated with different quercetin concentrations (0, 0.2, 0.5, 0.7, 1, and 10mM) for 1 h and then treated with 5mM H
2
O
2
for 20min.
Cells were immunoblotted with phosphotyrosine and 𝛽-actin (upper image). 𝛽-Actin is a loading control for this experiment.
reduces the oxidative stress caused by ischemia/reperfusion
in cardiomyocytes by inhibiting the xanthine dehydroge-
nase/xanthine oxidase system [6]. Several reports have also
indicated that quercetin and isorhamnetin can scavenge
ROS and inhibit the activation of ERK or MAP kinase
in ROS-induced cardiomyopathy [7, 8]. In cancer therapy,
combining quercetin with doxorubicin augmented the effects
of doxorubicin in highly invasive breast cancer cells [9]
and can protect cardiomyocytes from doxorubicin-induced
toxicity by chelating iron, inducing antioxidant activity, and
inhibiting carbonyl reductase [10]. Although quercetin has
been reported to play a role in protecting myocardial cells
from ischemia/reperfusion injury, its protective mechanism
remains unclear in current knowledge.
Ischemia/reperfusion injury in cardiomyocytes is the
result of myocardial inflammation [11]. Muthian and Bright
showed that quercetin blocks the IL-12-induced inflamma-
tory response through a signal transducer and activator of
transcription 3 (STAT3) activation in T lymphocytes [12].
However, previous research failed to show a direct relation-
ship between quercetin and STAT3-activated inflammation
in cardiomyocytes. STAT3 is a transcription factor that
plays an important role in numerous cytokine signaling
transductions including cell survival, proliferation, cell cycle
progression, and cell growth. STAT3 has two important
phosphorylated and activate sites: Tyr705 and Ser727. STAT3
activationwas phosphorylated at tyrosine 705 induced by var-
ious factors, including cardiotrophin-1, IL-6, tumor necrosis
factor-alpha (TNF-𝛼), and interferon-gamma (IFN-𝛾) [5, 13].
pY705-STAT3 is also essential for the dimerization of STAT3
and the translocation of STAT3 into the nucleus. In addition,
STAT3 has been observed to be phosphorylated at serine 727
under oxidative stress to enhance the transcription activity
of STAT3 in previous cerebral ischemia preconditioning
study [14]. Moreover, The JAK2/STAT3 signaling pathways
participate in an oxidative stress-induced immune response
[3, 15].
Two-dimensional gel electrophoresis (2-DE) is a com-
mon tool for analyzing thousands of proteins in different
biological samples and is complementary to LC-MS results.
However, varying quantification between gels remains the
primary challenge in 2-DE. Therefore, 2D-DIGE reduces the
variation between gels and gels, which codetected the sample
abundances on the same gel by using differential fluorescent
labeling [2].
This study investigates the potential protective role of
quercetin inH
2
O
2
-inducedH9C2 cell injury.We focus on the
correlation between quercetin in cardiomyocytes and the car-
dioprotective role of Src kinase inhibition and inflammatory
response of STAT3 using 2D-DIGE combined with MALDI-
TOF MS and immunoblotting.
2. Materials and Methods
2.1. Chemicals and Reagents. Quercetin was purchased from
Sigma-Aldrich (St. Louis, USA). The primary antibody
Evidence-Based Complementary and Alternative Medicine 3
Que 1 mM
−
− −
+ +
+
H2O2 5 mM
p-Src(Y416)
p-FAK
(a)
Control H2O2 Que + H2O2
F-Actin
ZO-2
𝛼-Tubulin
(b)
Control
H2O2
Que 
H2O2
+
0 h 6 h 24 h 30 h 42 h
(c)
Que + H2O2
C
el
l n
um
be
r (
%
)
Control
H2O2
Time (min)
1 h 4 h
∗ ∗
0
20
40
60
80
100
(d)
Figure 2: Effects of quercetin on the cell morphology, migration, and adhesion of H
2
O
2
-treated H9C2 cells. (a)The expressions of phospho-
Src (Tyr-416) and phospho-FAK (Tyr-576/577) in H9C2 cells were detected using immunoblotting. (b) The cell morphology and protein
location of proteins in H9C2 cells were analyzed by immunostaining. Each set of fluorescence images was taken at the same exposure time.
Scale bar = 20 𝜇m. (c) The wound healing images were captured at different culture times (0 h, 6 h, 24 h, 30 h, and 42 h) using a fluorescence
microscope (Zeiss) after H9C2 cells were treated with H
2
O
2
for 20min or pretreated with quercetin for 1 h. Scale bar = 100 𝜇m. (d) Adhesion
assays in which H9C2 cells were treated with H
2
O
2
for 20min or pretreated with quercetin for 1 h and then incubated for 1 h and 4 h in a
serum-free medium. After incubation, H9C2 cells were trypsinized, and the cell number was counted using a hemocytometer. Data represent
the mean ± standard deviation for 3 independent experiments and are represented as a percentage of the control. The control contains only
serum-free DMEM. (∗𝑃 < 0.05).
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Figure 3: Effects of quercetin on the inflammatory response in
H
2
O
2
-treatedH9C2 cells.The expressed levels of phospho-Akt (Ser-
473), phospho-p38 (Tyr-180/182), Mn-SOD, phospho-STAT3 (Tyr-
705), phospho-STAT3 (Ser-727), COX-2, and STAT3 in H9C2 cell
were detected by immunoblotting. GAPDH served as a loading
control.
phopho-FAK, Bax, caspase9, Bcl-2, GAPDH, and STIP1 were
purchased from Genetex (Hsinchu, Taiwan). Horseradish
peroxidase and fluorescence conjugated secondary antibod-
ies against mouse and rabbit were purchased from Sigma-
Aldrich (St. Louis, USA). Annexin V-FITC and a propidium
iodide (PI) labeling kit were purchased from Invitrogen.
We purchased 2,7-dichlorofluorescein diacetate (DCFH-DA)
from Molecular Probes. The chemicals and reagents of 2D-
DIGE were purchased from GE Healthcare (Uppsala, Swe-
den).
2.2. Cell Lines, Cell Culture, and Cell Treatment. The H9C2
rat cardiomyocyte cell line purchased from American Type
Culture Collection (Manassas, VA, USA) was chosen as a
cellular model for this study as this cell line retains the char-
acteristics of isolated primary cardiomyocytes and has been
used as a model in ischemia and reperfusion studies [2]. The
H9C2 was cultured in Dulbecco’s modified Eagle medium
(DMEM) (Invitrogen) containing 10% fetal bovine serum
(FBS) at 37∘C. Cells cultured in normal growth medium
were treated with various concentrations of H
2
O
2
for 20min.
H9C2 cells were pretreated with quercetin (Sigma) for 1 h
followed by treatment with H
2
O
2
for 20min.
2.3. Immunoblotting. The methods of quantifying and sep-
arating cell lysates for immunoblotting were similar to our
previous paper [2].The primary antibodies used in this study
included Src-phospho-Y416, phospho-FAK, phosphor-Y99,
phospho-AKT, p38, Bax, caspase9, Bcl-2, GAPDH, CDK4,
and STIP1.
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Figure 4: Effects of quercetin on ROS production in H
2
O
2
-treated
H9C2 cells. The level of ROS in H9C2 cells was analyzed using a
DCFH-DA assay. Values represent the mean ± standard variation
for 3 independent experiments performed in triplicate and are
represented as a ratio of the control. The control contains only
serum-free DMEM. (∗∗∗𝑃 < 0.001).
2.4. Immunostaining and Fluorescence Microscopy. For com-
pleting immunofluorescence staining, H9C2 cells grown on
coverslips (12mm) were treated with 5mM H
2
O
2
for 20min
alone, 1mM quercetin for 1 h prior to treatment with 5mM
H
2
O
2
for 20min, or left untreated [2]. The cell fixing,
immunostaining, and fluorescence image analysis methods
in this study were similar to our previous paper [2].
2.5. Wound Healing Assay. H9C2 cells (105 cells/well) were
incubated in 24-well plate at 37∘C for 12 h and then scraped
with a 10 𝜇L tip and treated with H
2
O
2
for 20min, pretreated
with quercetin, or left untreated. H9C2 cells were incubated
with medium containing 10% FBS, and a fluorescence micro-
scope captured images at different incubation times (0 h, 6 h,
24 h, 30 h, and 42 h).
2.6. Adhesion Assays. H9C2 cells (8 × 104 cells/well) were
incubated in a 3 cm dish containing DMEM containing 10%
FBS and treated with 1mM quercetin for 1 h followed by
5mM H
2
O
2
for 20min. After treatment, H9C2 cells were
incubated with serum-free medium for 1 h and 4 h and then
were counted.The cell culture environment and cell counting
were similar to our previous study [2]. All conditions have
been performed in duplicate-independent experiments.
2.7. Apoptosis Assay Using Flow Cytometry. H9C2 cells (106
cells) were labeled with annexin V-FITC and PI at room tem-
perature for 15min and treated with H
2
O
2
, pretreated with
quercetin, or left untreated. The FITC and PI fluorescence
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Figure 5: Effects of quercetin on cell apoptosis in H
2
O
2
-treated H9C2 cells. ((a), (b), and (c)) Typical dot plots of annexin V-FITC and PI are
cells untreated, H
2
O
2
treated, and quercetin pretreated followed by H
2
O
2
treatment. The 𝑥-axis and 𝑦-axis represent the intensity of annexin
V-FITC and PI, respectively. The lower left area of (a), (b), and (c) presented background staining by annexin V-FITC and PI in normal cells
and apoptosis signals located in the right area. This figure is representative of 3 replicates. (d) The full lengths of DNA in H9C2 cells were
detected by FACS. The 𝑥-axis shows the intensity of PI, and the 𝑦-axis shows the number of cells. (e) The levels of Bax, BCL-2, and caspase 9
in H9C2 cells were detected by immunoblotting. GAPDH served as a sample loading control.
signals were recorded by fluorescence-activated cell sorting
FACS (Accuri 6) and analyzed using CFlow plus software [2].
2.8. Reactive Oxygen Species in Cells Were Detected Using
DCFH-DA Assay. H9C2 cells (105 cells/well) were grown on
a 24-well plate, treated with H
2
O
2
for 20min, pretreated
with quercetin for 1 h, or left untreated. After washing, H9C2
cells were incubated with 10 𝜇M of 2,7-dichlorofluorescin
diacetate (DCFH-DA) at 37∘C for 20min. Fluorescence was
recorded by Spectra Max Gemini EM (Molecular Device)
at an excitation wavelength of 488 nm and an emission
wavelength of 504 nm [16, 17].
2.9. 2D-DIGE and Gel Image Analysis in Gel Digestion and
Protein Identification by MALDI-TOF MS. The experiments
in this study used Cy-Dye labeling and comparative quan-
tification methods to perform lysine-2D-DIGE analysis. Pro-
teins were identified through MALDI-TOF MS with peptide
mass fingerprinting (PMF) in our previous paper [2].
3. Results
3.1. Quercetin Pretreatment Suppresses Hydrogen Peroxide-
Induced Tyrosine Phosphorylation in Cardiomyocytes. H
2
O
2
,
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Figure 6: 2D-DIGE analysis of H9C2 cell proteome in response to H
2
O
2
and quercetin treatment. H9C2 cells were lysed and arranged for
a triplicate electrophoresis using pH 3 to 10 nonlinear, 24 cm IPG strips, and SDS-PAGE after treatment. 2D-DIGE image of protein sample
(Cy2) is shown here. The spot numbers represent differentially expressed proteins.
an important signal mediator, induces large scale of pro-
tein phosphorylation and protein modification resulting in
cellular physiology alteration including cell morphology,
adhesion, and viability. Because heart ischemia/reperfusion
injury stimulates H
2
O
2
production, H9C2 cells were treated
with varyingH
2
O
2
doses to find the optimal phosphotyrosine
response. The optimal response represents the maximal
ratio of phosphotyrosine intensity to H
2
O
2
concentration by
immunoblotting (Figure 1(a)). Results show that 5mMH
2
O
2
treatment led to a robust phosphotyrosine response, but the
phosphotyrosine response decreased in 10mM H
2
O
2
cells.
Quercetinmay also play an important role in oxidative stress-
damaged cells, and phosphotyrosine signals were detected
with a range of quercetin followed by treatment with 5mM
H
2
O
2
(Figure 1(b)).These results reveal that H9C2 pretreated
with 1mM quercetin and subsequently treated with 5mM
H
2
O
2
induced a lesser phosphotyrosine response than that
of H9C2 cells treated with 5mM H
2
O
2
. Subsequent experi-
ments were carried out based on these H
2
O
2
and quercetin
treatment concentrations.
3.2. Quercetin Inhibits Hydrogen Peroxide-Induced Changes in
Cell Morphology and Loss of Cell Adhesion. H
2
O
2
stimulates
the activation of Src kinase that regulates cytoskeleton, cell
adhesion, and cell motility. Previous report indicated that
PP1, a Src kinase inhibitor, inhibits H
2
O
2
-induced Src kinase
activation [2]. In this study, quercetin pretreatment reduces
the tyrosine phosphorylation of Src kinase and FAK inH
2
O
2
-
treated H9C2 cells (Figure 2(a)). The immunostained images
represent the H9C2 proteins against specific antibodies,
including cytoskeleton protein (F-actin and 𝛼-tubulin) and
cell-cell interaction protein (ZO-2). Oxidative damage affects
cytoskeleton proteins and ZO-2, effectively altering cell
morphology (Figure 2(b)). Quercetin pretreatment improved
changes in ROS-induced cell morphology.
In the wound healing assay, H9C2 cell images were
captured at different time points (0 h, 6 h, 24 h, 30 h, and
42 h) using a microscope (Zeiss). Cells were untreated, H
2
O
2
treated, and quercetin pretreated followed by hydrogen per-
oxide treatment (Figure 2(c)). After incubation, the closure
areas of H
2
O
2
-treated H9C2 cells were larger than those
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Figure 7: Representative images of identified proteins spots and MALDI-TOF MS analysis of (a) alpha-soluble NSF attachment protein
(𝛼-SNAP); (b) elongation factor 1-alpha 1 display differentially expressed proteins among untreated, H
2
O
2
treated, and quercetin-pretreated
followed by H
2
O
2
treatment. The differentially expressed levels of these proteins appear as 2D patterns (top images), 3D spot images (middle
images), and protein abundance levels (bottom images). The PMF patterns were ((c) and (d)) fromMALDI-TOF MS.
of untreated and quercetin pretreatment followed by H
2
O
2
treatment.
An adhesion assay was also performed to analyze the
effects of quercetin on ROS-damaged cardiomyocytes. H9C2
cells untreated, treated with H
2
O
2
alone, or pretreated with
quercetin were followed by treatment with H
2
O
2
. Cells were
then incubated in a serum-free medium for 1 h or 4 h. The
adherent cells were counted after incubation. Results show
that H
2
O
2
-treated cells had reduced adhesive ability; yet,
this could be significantly improved by pretreatment with
quercetin (Figure 2(d)). Thus, quercetin can stimulate cell
migration and maintain cell adhesion in H
2
O
2
-damaged
H9C2 cell.
3.3. Quercetin Inhibits Phosphorylation of STAT3, PI3K/Akt,
and p38 Kinase and the Expression of COX-2 in H
2
O
2
-Induced
H9C2 Cells. To determine whether quercetin affects cell
signalings associated with inflammatory response and cell
proliferation, we examined the activation of AKT, p38,
and STAT3 and the expression of COX-2 and MnSOD in
ROS-induced cardiomyocytes. Results show that excess ROS
increased the phosphorylation of Akt, p38, and STAT3 (Tyr-
705 and Ser-727) and the level of COX-2 but repressed the
expression of MnSOD in H9C2 cells. Quercetin significantly
reduces the phosphorylation of STAT3 and level of COX-
2 and increases the expression of MnSOD in H
2
O
2
-treated
cells (Figure 3). These results show that quercetin suppresses
inflammation in H
2
O
2
-induced H9C2 cells.
3.4. Pretreatment with Quercetin Suppresses ROS Production
in H
2
O
2
-Treated H9C2 Cells. DCF fluorescence revealed
ROS production in H9C2 cells induced by oxidative damage.
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Figure 9: Comprehensive immunofluorescence images and immunoblotting analysis of the differentially expressed proteins identified by
MALDI-TOF MS. (a) The differential expression and distribution of 𝛼-SNAP in H9C2 cells responded to H
2
O
2
and quercetin (Que) were
analyzed using immunofluorescence. (b) Immunoblotting was performed to validate CDK4 and STIP1 in the H9C2 cell lysate. 𝛼-Tubulin
served as a loading control. Scale bar = 20 𝜇m.
Excess ROS accumulated in H
2
O
2
-induced H9C2 cells, but
quercetin significantly inhibitedH
2
O
2
-induced ROS produc-
tion in cardiomyocytes (Figure 4).
3.5. Quercetin Reduces Hydrogen Peroxide-Induced H9C2
Cell Apoptosis. Excess ROS production from ischemia/
reperfusion-injured cardiomyocyte [18] alters redox home-
ostasis and induces cell apoptosis. During cell apoptosis,
the asymmetric distribution of phospholipids of the plasma
membrane gets lost and phosphatidylserine is translocated
to the outer surface of the plasma membrane which has a
high affinity to annexin V-FITC. PI can penetrate the cell
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Figure 10: Model illustrating how quercetin protects cardiomyocytes from ROS treatment. ROS activates Src kinase and the overexpression
of 𝛼-SNAP. ROS-induced 𝛼-SNAP causes phospho-Src-FAK complexes to move from the cytosol to a nearby inner cell membrane. ROS-
activated p-Src and p-p38 stimulate the phosphorylation of STAT3 at tyrosine 705 and serine 727. After p-Src kinase and p-p38 activated
STAT3, the p-STAT3 dimerized to translocate into nucleus. The dimerization of p-STAT3 induces the proinflammatory response gene
expression (i.e., COX-2) in oxidative stress. Ena/VASP-like protein (Evl), which participates in actin binding and homologous recombination,
is upregulated in ROS-induced cells and can repair ROS-damaged DNA. Elongation factor 1-alpha 1 (Eef1a1) decreased in oxidative stress
resulting in cell death. Myosin regulatory light polypeptide 9 (Myl9), profilin-1 (Pfn1), and Eef1a1 are correlated with cytoskeleton, whichmay
induce cell deadhesion and apoptosis. ROS inhibited the expression of isopentenyl-diphosphate delta-isomerase 1 (Idi1) in cells thatmay block
the formation of lipophilic molecular such as sterols, ubiquinones, and terpenoids. Quercetin may protect ROS-damaged cardiomyocytes via
these routes (stop sign in red). The proteins (red) were altered in a H
2
O
2
-dependant manner but reverted by pretreatment with quercetin.
nucleus when cells undergo apoptosis. Cell apoptosis was
detected using FACS. The dot plots of annexin V and PI
staining are analyzed using FACS, appearing in Figures 5(a),
5(b), and 5(c). The cell apoptosis rate increased from 5%
to 12.5% upon H
2
O
2
treatment, whereas the cell apoptosis
rate decreased to 5.5% after H9C2 cells were pretreated with
quercetin before H
2
O
2
treatment. In addition, the PI staining
signal of H
2
O
2
-treated H9C2 shifted forward, compared to
that of untreated cells and cells pretreated with quercetin
followed by H
2
O
2
(Figure 5(d)). The levels of Bax, Caspase 9,
and Bcl-2 were detected using immunoblotting for untreated
H9C2 cells, treated H
2
O
2
, and pretreated quercetin followed
by H
2
O
2
treatment. ROS increased the expression level
of apoptosis factors caspase 9 and Bax and reduced anti-
apoptosis marker Bcl-2 expression (Figure 5(e)). According
to the data, quercetin can protect and stabilize the total
chromosome of DNA in H9C2 cells from oxidative damage
by inhibiting cell apoptosis and chromosome attrition.
3.6. 2D-DIGE Analysis of Untreated and H
2
O
2
-Treated H9C2
Cells and Quercetin Pretreatment Followed by Treatment
with H
2
O
2
. Three types of cell lysates were analyzed using
2D-DIGE. The results of 2D-DIGE analysis and DeCyder
processing identified 1535 proteins spots, and 44 proteins
showed differential expression (≧1.5-fold or ≦ −1.5-fold;
𝑃 < 0.05) among these 3 conditions (Figure 6). Table 1
shows that 44 proteins were identified using MALDI-TOF
MS and 17 protein spots of the 44 identified protein spots
that displayed H
2
O
2
-dependent alteration could be reversed
by pretreatment with quercetin (Table 1, boldface numbers).
For example, the alpha-soluble NSF attachment protein
(𝛼-SNAP) (No.990) was upregulated (9.85-fold) in H
2
O
2
-
treated cells, whereas quercetin reduced the overexpression
of H
2
O
2
-treated 𝛼-SNAP (7.69-fold). Protein spot number
1405, which was identified as profilin-1, was downregulated
in H
2
O
2
treatment only (−3.01-fold) but showed no signif-
icant expression after quercetin pretreatment followed by
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H
2
O
2
treatment (1.12-fold). These results suggest that the
protective mechanisms of quercetin significantly reduced
H
2
O
2
-induced damage in cardiomyocytes. Figure 7 shows
the 2D-gel images, 3D images, and protein abundances from
untreated, H
2
O
2
treated, and quercetin pretreated followed
by H
2
O
2
cells.
Figure 8 shows the functional distribution of identified
proteins from 2D-DIGE results. Most of proteins identi-
fied using MALDI-TOF MS are related to the cytoskeleton
(9%), redox regulation (9%), and protein degradation (14%),
implying that quercetin can reverse ROS damage to the
cytoskeleton and redox homeostasis in cardiomyocytes.
3.7. Verification by Immunoblotting and Immunostaining. The
levels of the alpha-soluble NSF attachment protein (𝛼-SNAP)
and cell division protein kinase 4 (CDK4) were examined by
immunoblotting or immunostaining to validate the results of
2D-DIGE analysis. These results indicate that 𝛼-SNAP and
CDK4 were overexpressed in response to H
2
O
2
. However,
quercetin suppressed ROS-induced 𝛼-SNAP and CDK4 pro-
tein expression in H9C2 cells (Figures 9(a) and 9(b)). These
data are consistent with 2D-DIGE results.
4. Discussions
Cardiovascular diseases have become a primary health con-
cern worldwide in recent years. Ischemia/reperfusion injury
in cardiomyocytes, which leads to excess ROS generation,
is a particularly serious result of cardiovascular diseases.
Many studies have focused on how to alleviate ischemia
reperfusion-induced ROS in cardiomyocytes. For exam-
ple, many plant molecules, including resveratrol, quercetin,
sasanquasaponin, proanthocyanidin, safflower, and orientin,
function as protectors in ischemia/reperfusion-damaged car-
diomyocytes [19–23]. However, the role of quercetin in
the ischemia/reperfusion injury of cardiomyocytes remains
unclear.
According to previous reports, Src kinase regulates many
cell signals, including cell adhesion, migration, proliferation,
and apoptosis [24, 25]. During oxidative stress, Src kinase
induces cell death by inactivating PI-3 K, cell migration,
and spreading [26]. PP1, a Src kinase inhibitor, can rescue
ROS-damaged H9C2 cells by inhibiting cell apoptosis and
enhancing cell adhesion/viability [2]. However, the inhibition
of Src kinase activity with PP1 is generally unsuitable for
mammalian cells. Alternatively, in our findings, H9C2 cells
pretreated with quercetin for 1 h are protected against H
2
O
2
-
induced apoptosis in this study. The role of quercetin in
H
2
O
2
-treated cardiomyocytes is to inhibit inflammatory
response and maintain cell physiology, including morphol-
ogy, redox status, and metabolism, by regulating Src kinase,
FAK, and STAT3.
The results of this study indicate that H
2
O
2
stimulates the
tyrosine phosphorylation of Src kinase and FAK, which affect
cell morphology and tight junction proteins, leading to cell
detachment [27]. Quercetin, however, inhibits the tyrosine
phosphorylation of Src kinase and FAK which maintain cell-
cell interaction and morphology. Many studies have shown
that quercetin protects retina, testis, neuron, cerebral, and
cardiovascular cells from ischemia/reperfusion injury [28–
31]. This study further demonstrates that quercetin increases
migration and survival in H
2
O
2
-treated cardiomyocytes
(Figure 2).
𝛼-SNAP is a component of the solubleN-ethylmaleimide-
sensitive fusion factor attachment protein receptors
(SNAREs) complex required for vesicular transport between
the endoplasmic reticulum and the Golgi apparatus.
The major function of 𝛼-SNAP is to recycle the SNARE
complex. Several reports have shown that SNARE-
dependent trafficking is required for integrin signaling
through a FAK/Src/PI3 K-dependent pathway [32], and
the inhibition of SNARE-mediated exocytosis attenuates
ischemia/reperfusion injury [33]. 𝛼-SNAP may play a
critical role in regulating Src kinase signaling and inducing
ischemia/reperfusion injury in cardiomyocytes. This study
shows that 𝛼-SNAP was robust to overexpression (9.85-fold)
in 5mM H
2
O
2
-treated H9C2 cells. However, pretreatment
with quercetin reduced H
2
O
2
-induced 𝛼-SNAP expression.
Quercetin inhibits ROS-induced 𝛼-SNAP overexpression
in cardiomyocytes, which could be effectively applied for
protecting cardiomyocytes from oxidative stress (Figure 10).
The major functions of the Ena/VASP-like (Evl) protein
include the regulation of cytoskeletal dynamics and organiza-
tion axon guidance, platelet aggregation, cell motility, and cell
adhesion [34, 35]. However, several studies have shown that
the Evl protein has another function in homologous pairing
and strand exchange through interaction with RAD51 and
RAD51B [36]. Because H
2
O
2
targets DNA, oxidative stress
causes base damage such as strand breaking in DNA. At
this moment, the repaired mechanisms, including base exci-
sion repair (BER), transcription-coupled repair (TCR), mis-
match repair (MMR), nonhomologous end-joining (NHEJ),
translesion synthesis (TLS), global genome repair (GGR),
and homologous recombination (HR), will been turned on
[37]. ROS-treated cells exhibited DNA damage, stimulating
homologous recombination. In this case, Evl expression
increased in cardiomyocytes, but quercetin pretreatment
reduced the expression of ROS-induced Evl (Figure 10). This
suggests that quercetin may stabilize the DNA structure of
ROS-damaged cardiomyocytes.
Isopentenyl-diphosphate delta-isomerase 1, which is
located in peroxisomes, catalyzes the isomerization of 1,3-
allylic rearrangement of the homoallylic substrate isopen-
tenyl (IPP) to dimethylallyl diphosphate (DMAPP), which is
a strong electrophile allylic isomer. DMAPP is also an impor-
tant product in the synthesis of many lipophilic molecules
such as sterols, ubiquinones, and terpenoids. Yochem et al.
demonstrated that losing idi-1 gene is lethal inCaenorhabditis
elegans, leading to accumulated and enlarged lysosomes and
autophagosomes [38]. This study shows that ROS-treated
block isopentenyl-diphosphate delta-isomerase 1 expression
may induce cell death; however, quercetin pretreatment
reversed isopentenyl-diphosphate delta-isomerase 1 expres-
sion in H9C2 cell (Figure 10).
Elongation factor 1-alpha (EF-1 alpha) is a multifunc-
tions protein that promotes peptide synthesis through GTP-
dependent binding of aminoacyl-tRNA to the A-site of
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ribosomes and binds to filamentous actin [39] and severs
microtubules, leading to abnormal tetraploid cells and cell
death [40]. In 1996, GaŁasin´ski demonstrated that quercetin
prevents the peptide elongation by interacting with EF-
1 alpha in plant [41]. The present data show that H
2
O
2
downregulates the expression of EF-1 alpha in H9C2 cells,
whereas quercetin pretreatment reverses the expression of
EF-1 alpha. Quercetin can prevent ROS-induced cytoskeleton
damage and promote protein synthesis in cardiomyocytes
(Figure 10).
Cellular antioxidant enzymes including superoxide dis-
mutases (Mn-SOD and CuZn-SOD), catalase (CAT), perox-
idases, and glutathione S-transferases regulate redox home-
ostasis in mammalian cells. Catalase and peroxidases scav-
enge H
2
O
2
or convert it to hydroxyl radicals. Superoxide
dismutases convert superoxide anions (O2−) to H
2
O
2
. The
observation of the oxidative state in this study demonstrates
that ROS inhibits the MnSOD expression that leads to O2−
accumulation in cell. However, quercetin pretreatment not
only reduces ROS production, but also prevents MnSOD
expression in H
2
O
2
-treated H9C2 cells (Figure 3).
Inflammation contributes to the pathophysiology of
cardiac ischemia/reperfusion injury. Myocardial ischemia
and reperfusion, sepsis, viral myocarditis, and immune
rejection induce the inflammatory response [11]. Cardiac
ischemia/reperfusion is an acute inflammatory response that
may activate phospholipase A2, metabolizing arachidonic
acid into inflammatory factors by cyclooxygenases (COX-
1 and COX-2), cytochrome P450, and lipoxygenase. These
enzymes increase ROS production in the mitochondria.
Xanthine oxidase and NADPH oxidase, which produce ROS
in cells, result in inflammatory gene expression.These results
suggest that quercetin blocks ROS-induced inflammatory
responses such as COX-2, which converts arachidonic acid
to prostaglandin (Figure 10).
STAT3, which belongs to the STAT protein family, is
a protein transcription factor regulating many downstream
signals for cell survival, apoptosis, proliferation, angiogen-
esis, and metabolic and anti-oxidative pathways [42]. Pre-
vious reports mentioned that oxidative stress activates the
JAK2/STAT3/IL6 signal pathway in obese Zucker rats’ fatty
livers [15]. Furthermore, ROS production in hepatoma cells
infected with Hepatitis C virus (HCV) activated STAT3
through JAK, Src kinase, and p38MAP kinase pathways [43],
and the decreased phosphorylation of p38 MAPK blocks the
oxidative stress-induced senescence ofmyeloid leukemic cells
[44]. PI-3K/AKT pathways, playing an important role in cell
survival, proliferation, and growth, were activated by IL-1,
leading to the proinflammatory gene activation of NF-𝜅B
regulation. This study shows that H
2
O
2
induced the phos-
phorylation of Src kinase, AKT, p38, and STAT3 (pY-705 and
pS-727) in cardiomyocytes inhibited by pretreatment with
quercetin. Quercetin protects H9C2 cells from ROS-induced
hyperinflammatory responses that inhibit the activation of
Src, p38, and STAT3 (Figure 10).
In summary, this study shows that quercetin inhibits
Src kinase, a potential therapeutic target in vitro, and
kinases such as FAK, p38, and STAT3. Thus, quercetin has
comprehensive effects on cardiomyocyte. The inhibition of
an inflammatory response through STAT3 inactivation in
cardiomyocytemay be beneficial for an ischemia/reperfusion
injury model. Hence, quercetin should be tested in an animal
model to verify its therapeutic role.
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